Hypertension, Hyperlipidemia Clinical Trial
Official title:
A Randomized, Open Label, Multiple Dose, Cross-over, Phase I Trial to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
Primary objective : To investigate pharmacokinetics after concomitant administration of
valsartan and rosuvastatin compared to single administration of valsartan or rosuvastatin in
healthy male volunteers
Secondary objective : To investigate safety profiles after the administration of valsartan
or rosuvastatin alone and concomitant administration of valsartan and rosuvastatin in
healthy male volunteers
n/a
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03847506 -
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
|
Phase 4 | |
| Completed |
NCT02994745 -
A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.
|
Phase 1 | |
| Completed |
NCT02995720 -
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
|
Phase 1 |